1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma

BMC Endocrine Disorders

Jesús Zacarías Villarreal-Pérez²  José Gerardo González-González²  Fernando Javier Lavalle-Gonzalez²  Carlos Rodrigo Camara-Lemarroy¹  Dania Lizeth Quintanilla-Flores¹  Maria Azucena Zapata-Rivera²  René Rodríguez-Gutiérrez² 

[1] Internal Medicine Department, University Hospital “Dr. José E. González”, Monterrey, Nuevo León 64460, Mexico;Medical School of the Universidad Autónoma de Nuevo León, Ave. Madero y Ave. Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo León 64460, Mexico

关键词: Seminoma;    Malignant hypercalcemia;    PTHrP;    Calcitriol;    1,25-dihydroxyvitamin D;   

Others  :  864936
DOI  :  10.1186/1472-6823-14-32

 received in 2013-09-28, accepted in 2014-03-17,  发布年份 2014

【 摘 要 】

Background

Seminomas have been rarely associated with malignant hypercalcemia. The responsible mechanism of hypercalcemia in this setting has been described to be secondary to 1,25-dihydroxyvitamin D secretion. The relationship with PTHrP has not been determined or studied.

The aim of this study is to describe and discuss the case and the pathophysiological mechanisms involved in a malignant hypercalcemia mediated by 1,25-dihydroxyvitamin D and PTHrP cosecretion in a patient with seminoma.

Case presentation

A 35-year-old man was consulted for assessment and management of severe hypercalcemia related to an abdominal mass. Nausea, polyuria, polydipsia, lethargy and confusion led him to the emergency department. An abdominal and pelvic enhanced CT confirmed a calcified pelvic mass, along with multiple retroperitoneal lymphadenopathy. Chest x-ray revealed “cannon ball” pulmonary metastases. The histopathology result was consistent with a seminoma. Serum calcium was 14.7 mg/dl, PTH was undetectable, 25-dihydroxyvitamin D was within normal values and PTHrP and 1,25-dihydroxyvitamin were elevated (35.0 pg/ml, and 212 pg/ml, respectively). After the first cycle of chemotherapy with bleomycin, etoposide and cisplatin, normocalcemia was restored. Both PTHrP and 1,25-dihydroxyvitamin D, dropped dramatically to 9.0 pg/ml and 8.0 pg/ml, respectively.

Conclusion

The association of seminoma and malignant hypercalcemia is extremely rare. We describe a case of a patient with a seminoma and malignant hypercalcemia related to paraneoplastic cosecretion of 1,25-dihydroxyvitamin D and PTHrP. After successful chemotherapy, calcium, PTHrP and 1,25-Dihydroxyvitamin D returned to normal values.

【 授权许可】

   
2014 Rodríguez-Gutiérrez et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Stewart AF, Broadus AE: Malignancy associated hypercalcemia. In Endocrinology. 5th edition. Edited by DeGroot L, Jameson LJ. Philadelphia: Saunders; in press
• [2]Stewart AF: Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005, 352(4):373-379.
• [3]Ralston SH, Gallagher SJ, Patel U, Campbell J, Boyle IT: Cancer-associated hypercalcemia: morbidity and mortality: clinical experience in 126 treated patients. Ann Intern Med 1990, 112:499-504.
• [4]Horwitz MJ, Stewart AF: Humoral Hypercalcemia Of Malignancy. In Primer On The Metabolic Bone Diseases And Disorders Of Mineral Metabolism. 5th edition. Edited by Favus MF. Washington D.C: American Society for Bone and Mineral Research; 2003:246-250.
• [5]Roodman GD: Mechanisms of bone metastasis. N Engl J Med 2004, 350:1655-1664.
• [6]King WW, Cox CE, Boyce WH: Pseudohyperparathyroidism and seminoma. J Urol 1972, 107:809-811.
• [7]Metcalfe JB, Carey TC, Barry JM: Genitourinary malignancy and pseudohyperparathyroidism. J Urol 1978, 119:702-704.
• [8]Grote TH, Hainsworth JD: Hypercalcemia and elevated serum calcitriol in a patient with seminoma. Arch Int Med 1987, 147:2212-2213.
• [9]da Silva MA, Edmondson JW, Eby C, Loeher PJ: Humoral hypercalcemia in seminomas. Med Pediatr Oncol 1992, 20:38-41.
• [10]Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61(4):212.
• [11]Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 1997, 337(4):242.
• [12]Doyle MA, Malcolm JC: An unusual case of malignancy- related hypercalcemia. Int J Gen Med 2014, 7:21-27.
• [13]Kandil E, Noureldine S, Khalek MA, Daroca P, Friedlander P: Ectopic secretion of parathyroid hormone in a neuroendocrine tumor: a case report and review of the literature. Int J Clin Exp Med 2011, 4(3):234-240.
• [14]Jacobs TP, Bilezikian JP: Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab 2005, 90(11):6316.
• [15]Seymour JF, Gagel RF: Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and non-Hodgkin's lymphomas. Blood 1993, 82(5):1383.
• [16]MacDiarmid SA, Norman RW: Extragonadal nonseminomatous germ cell tumour with hypercalcemia, masquerading as renal cell carcinoma: a case report. Can J Surg 1995, 38:80-82.
• [17]Sorscher S: Elevated parathyroid hormone-related peptide in a patient with an extragonadal germ-cell tumour and hypercalcemia. Can J Surg 2004, 47(2):144. No abstract available
• [18]Bikle DD: Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications. Clinic Rev Bone Miner Metab 2009, 7:114.
• [19]Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS: Extra-renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007, 103(3–5):316-321.
• [20]Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS: Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 2003, 18(3):579-582.
• [21]Evans KN, Taylor H, Zehnder D, Kilby MD, Bulmer JN, Shah F, Adams JS, Hewison M: Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol 2004, 165(3):807-813.
• [22]Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocaña A, Wisniewski SR, Stewart AF: Parathyroid hormone-related protein-(1–36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J Clin Endocrinol Metab 2001, 86(4):1525-1531.
• [23]Giannini S, Nobile M, Castrignano R, Pati T, Tasca A, Villi G, Pellegrini F, D'Angelo A: Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin Sci 1993, 84:51-54.
• [24]Fraher LJ, Hodsman AB, Jonas K, Saunders D, Rose CI, Henderson JE, Hendy GN, Goltzman D: A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab 1992, 75(2):417.